| 2024/04/18 15:30:00 | |
|---|---|
| Price | |
| 9.17 USD | |
| Difference | -4.42% (-0.42) |
General attributes
| ISIN | JP3942400007 |
| Symbol | 4503 |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,106 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 9.17 USD |
| High | 9.17 USD |
| Low | 9.17 USD |
| Close (prev. day) | 9.594 USD |
| VWAP | 9.17 USD |
| Volume (pcs) | 5,540 |
| Trading volume | 52,659.65 |
| Number of trades | 3 |
| Last size | 100 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: ASTELLAS PHARMA INC. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 15:30:00 | |
|---|---|
| Price | |
| 9.17 USD | |
| Difference | -4.42% (-0.42) |
General attributes
| ISIN | JP3942400007 |
| Symbol | 4503 |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 16,106 EUR |
| Benchmark | NIKKEI 225 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 9.17 USD |
| High | 9.17 USD |
| Low | 9.17 USD |
| Close (prev. day) | 9.594 USD |
| VWAP | 9.17 USD |
| Volume (pcs) | 5,540 |
| Trading volume | 52,659.65 |
| Number of trades | 3 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -26.37% | - | -35.00% |
| Perf (abs.) | -3.44 | - | -5.17 |
| Beta | 0.35 | 0.58 | 0.62 |
| Volatility | 38.10 | 30.99 | 29.77 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 9.81 USD (812) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 10.69 USD (1,366) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 11.47 USD (3,917) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 13.02 USD (2,876) |
| YTD High | date | 12.52 USD (2024/01/05) |
| YTD Low | date | 9.13 USD (2024/04/16) |
| 52 Weeks High | date | 17.00 USD (2023/05/25) |
| 52 Weeks Low | date | 9.13 USD (2024/04/16) |
All listings for ASTELLAS PHARMA INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Berlin | 2024/04/18 | 13:09 | 8.95 EUR | 0.00 | 4 |
| Duesseldorf | 2024/04/18 | 12:30 | 8.854 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/04/18 | 15:30 | 9.17 USD | 0.05 | 3 |
| Frankfurt | 2024/04/18 | 09:32 | 8.686 EUR | 0.00 | 1 |
| Munich | 2024/04/18 | 08:02 | 8.906 EUR | 0.00 | 1 |
| Stuttgart | 2024/04/18 | 11:04 | 8.88 EUR | 0.01 | 2 |
| Tokyo Stock Exchange | 2024/04/18 | 08:00 | 1,465.50 JPY | 94.55 | 4,819 |
| Tradegate | 2024/04/18 | 11:40 | 9.00 EUR | 0.00 | 4 |
Company Logo
Contact Details
| ASTELLAS PHARMA INC. |
| - - |
| 2-5-1 Nihonbashi-Honcho, Chuo-Ku - 103-8411 Tokyo |
| Telefon: +81-3-3244-3000 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: ASTELLAS PHARMA INC. | |
Company Profile
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan. |
Members of Management Board
| Kenji Yasukawa | Chairman of Managing Board |
| Bernie Zeiher | Member of Executive Committee |
| Catherine Levitt | Member of Executive Committee |
| Fumiaki Sakurai | Member of Executive Committee |
| Hideki Shima | Member of Executive Committee |
| Minoru Kikuoka | Member of Executive Committee |
| Naoki Okamura | Member of Executive Committee |
| Yoshihtsugu Shitaka | Member of Executive Committee |
| Yukio Matsui | Member of Executive Committee |
Board of directors
| Kenji Yasukawa | Chairman of Supervisory Board |
| Eriko Sakurai | Member of Supervisory Board |
| Haruko Shibumura | Member of Supervisory Board |
| Hiroko Sakai | Member of Supervisory Board |
| Hiroo Sasaki | Member of Supervisory Board |
| Hiroshi Kawabe | Member of Supervisory Board |
| Katsuyoshi Sugita | Member of Supervisory Board |
| Mamoru Sekiyama | Member of Supervisory Board |
| Mika Nakayama | Member of Supervisory Board |
| Noriyuki Uematsu | Member of Supervisory Board |
| Takashi Tanaka | Member of Supervisory Board |
| Tatsuro Ishizuka | Member of Supervisory Board |
| Tomokazu Fujisawa | Member of Supervisory Board |